# Asia Regenerative Medicine

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/asia-regenerative-medicine

- Industry: Biotechnology
- Headquarters: Shenzhen, China
- Website: www.asiaregen.com
- Latest round: Series A (Oct 30, 2025)
- Investors on record: 1

## About

Established in 2018 and based in Shenzhen, China, Asia Regenerative Medicine is a company that prepares implantable bio-artificial organs with stem cell and tissue engineering device technology as the core. The company was founded by several medical experts, transplant physicians and university professors, and collaborated to introduce projects from Harvard University and University of Toronto Medical School. The company is headquartered in Shenzhen, with cell and material laboratories in Guangzhou, Wuhan and Hong Kong, and joint polymer material and cell laboratories in Shanghai University and Sun Yat-sen University. In October 2025, Asia Regenerative Medicine raised a series A funding from new investor Dongna Investment.

The Company's products include iPS-induced differentiated renal progenitor cells, urine-derived renal precursor cells, in vitro artificial kidneys, and implantable artificial kidneys for the treatment of nephropathy, and iPS/ES-induced differentiated pancreatic islet cells, and biosynthesized artificial pancreas for diabetes.
The company generates revenue through providing stem cell and tissue engineering technologies to develop stem cells, exosomes, drugs, dialysis enhancement, and manufacture implantable bioartificial kidneys for kidney diseases, aiming to solve the problems of kidney CKD functional decline, end-stage diseases, and organ transplant shortages.
The series A round of financing will be primarily used for the clinical application and clinical trials of iNPC101 human renal progenitor cell injection derived from iPSCs, the registration clinical research of the AK00 blood filtration enhancement device, and the company's daily operations and team expansion.

## Funding rounds

- Series A, Oct 30, 2025 — Dongna Investment

## Investors

- Dongna Investment (https://capitalatlas.ai/funds/dongna-investment) — Series A